SCHEMBL5314928

SCHEMBL5314928

CN(C)c1ccc(N)cc1-c1nccc(-c2c[nH]c3ccccc23)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 5/20 0.58
▸ GSK3B P49841 5/20 0.58
▸ MAP3K14 Q99558 4/20 0.58
▸ CLK1 P49759 3/20 0.58
▸ CDK5 Q00535 3/20 0.58
▸ CDK5R1 Q15078 3/20 0.58
▸ EIF2AK2 P19525 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NCOA2 Q15596 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ FLT3 P36888 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20030496 0.80 DYRK1A (0.72) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL145566 0.78 GSK3B (0.70) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL29488162 0.75 GSK3B (1.00) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL573402 0.75 GSK3B (1.00) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL28230580 0.73 CLK1 (0.67) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL4564892 0.72 DYRK1A (0.68) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL29534011 0.69 DYRK1A (0.68) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL3818537 0.69 DYRK1A (0.68) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL7496465 0.69 DYRK1A (0.63) DYRK1AGSK3BMAP3K14CLK1CDK5
SCHEMBL20691186 0.69 EIF2AK2 (0.67) DYRK1AGSK3BMAP3K14CLK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836194-A1 4- (1H-INDOL-3-YL) -PYRIMIDIN-2-YLAMINE DERIVATES AND THEIR USE IN THERAPY Cyclacel Limited (GB) 2007-09-26 — — EP disclosed
WO-2006075152-A1 4- (1H-INDOL-3-YL) -PYRIMIDIN-2-YLAMINE DERIVATES AND THEIR USE IN THERAPY CYCLACEL LIMITED (GB) 2006-07-20 — — WO disclosed
Send feedback